Eton Pharmaceuticals jumps on strong Q2 print, 2026 guidance (ETON:NASDAQ)
· seekingalpha.com
Eton Pharmaceuticals stock surged 25% premarket on strong earnings and a 2026 revenue forecast over $145M.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...